Clinical trial
Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
NCT00130754 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00130754 |
|---|---|
| Title | Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation |
| Official title | A Prospective Randomized, Controlled Pilot Study in Order to Evaluate the Place of Thymoglobuline in Non-myeloablative Allogeneic Hemapoietic Stem-cell Transplantation (NST) |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stem Cell Transplantation, Graft Vs Host Disease |
| Intervention type | Drug |
| Interventions | Thymoglobuline |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Aug 16, 2005 |
| Last update posted | Feb 23, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: